Allogene Therapeutics (ALLO) stock Forecast for 2022, 2023, 2024, 2025

The forecast has been updated: June 25, 2022 12:52


Allogene Therapeutics stock price online today

Analyst Target Price

26.06

Dividend Date

-

Ex Dividend Date

-

Last Split Factor

Last Split Date

01.01.1970

Should you buy or sell Allogene Therapeutics stock today? What is the projected target price level for over the horizon of a year, two, three? How much will be worth in 2022, 2023, 2024?

We predict the dynamics of the stock market value using resonant artificial intelligence systems.

Technical, fundamental analyzes, news background, general geopolitical situation in the world and other factors are taken into account.

Below you can see the results of forecasts for the month, current and future years. Find out target values for stocks, optimistic and pessimistic forecasts.

Forecasts are adjusted once a day taking into account the price change of the previous day.

To date, analysts have a $26.06 target price for Allogene Therapeutics stock stock.

Today 200 Day Moving Average is the resistance level (13.7 $).

50 Day Moving Average is the resistance level (8.36 $).




Allogene Therapeutics stock monthly Forecast

Date Rate Forecast MIN Rate MAX Rate Volati-
lity, %
27 Jun 22 12.09 11.50 12.73 10.67 %
28 Jun 22 11.85 11.21 12.43 10.88 %
29 Jun 22 11.87 11.64 12.15 4.43 %
30 Jun 22 11.90 11.62 12.24 5.31 %
01 Jul 22 12.13 11.66 12.40 6.33 %
02 Jul 22 12.52 11.88 12.89 8.48 %
03 Jul 22 12.87 12.64 13.51 6.92 %
04 Jul 22 13.29 12.66 13.91 9.85 %
05 Jul 22 13.02 12.73 13.46 5.72 %
06 Jul 22 13.44 13.14 13.79 4.94 %
07 Jul 22 12.76 12.49 13.26 6.15 %
08 Jul 22 13.21 12.93 13.79 6.65 %
09 Jul 22 13.89 13.45 14.65 8.96 %
10 Jul 22 13.78 13.05 14.18 8.65 %
11 Jul 22 13.31 13.07 13.50 3.28 %
12 Jul 22 12.89 12.37 13.13 6.12 %
13 Jul 22 12.69 12.25 13.28 8.41 %
14 Jul 22 13.22 12.50 13.75 10.00 %
15 Jul 22 12.69 12.46 13.13 5.34 %
16 Jul 22 12.89 12.37 13.23 7.01 %
17 Jul 22 12.99 12.76 13.42 5.13 %
18 Jul 22 13.03 12.49 13.69 9.64 %
19 Jul 22 12.86 12.37 13.49 9.10 %
20 Jul 22 12.49 12.29 12.72 3.49 %
21 Jul 22 13.03 12.34 13.73 11.24 %
22 Jul 22 13.52 12.89 14.14 9.69 %
23 Jul 22 13.01 12.56 13.26 5.58 %
24 Jul 22 12.25 11.72 12.47 6.44 %
25 Jul 22 12.04 11.76 12.33 4.87 %
26 Jul 22 11.36 10.88 11.90 9.36 %

ALLO daily forecast for this month


Allogene Therapeutics stock forecast for 27.06.2022.
Estimated Average Forecasted Allogene Therapeutics Price: 12.09 Negative intraday dynamics of the instrument is expected with 9.644% volatility is expected.

Pessimistic forecast: 11.50

Optimistic: 12.73


Allogene Therapeutics stock forecast for 28.06.2022.
Estimated Average Forecasted Allogene Therapeutics Price: 11.85 Negative intraday dynamics of the instrument is expected with 9.809% volatility is expected.

Pessimistic forecast: 11.21

Optimistic: 12.43


Allogene Therapeutics stock forecast for 29.06.2022.
Estimated Average Forecasted Allogene Therapeutics Price: 11.87 Positive intraday dynamics of the instrument is expected with 4.240% volatility is expected.

Pessimistic forecast: 11.64

Optimistic: 12.15


Allogene Therapeutics stock forecast for 30.06.2022.
Estimated Average Forecasted Allogene Therapeutics Price: 11.90 Positive intraday dynamics of the instrument is expected with 5.039% volatility is expected.

Pessimistic forecast: 11.62

Optimistic: 12.24


Allogene Therapeutics stock forecast for 01.07.2022.
Estimated Average Forecasted Allogene Therapeutics Price: 12.13 Positive intraday dynamics of the instrument is expected with 5.957% volatility is expected.

Pessimistic forecast: 11.66

Optimistic: 12.40


ALLO Forecast for 2022

Month Rate Forecast MIN Rate MAX Rate Volati-
lity, %
Jul 10.60 10.35 11.16 7.22 %
Aug 10.77 10.40 11.42 8.95 %
Sep 10.47 10.02 10.95 8.51 %
Oct 9.42 9.11 10.05 9.37 %
Nov 8.79 8.51 9.40 9.45 %
Dec 9.26 8.92 9.83 9.24 %

Allogene Therapeutics stock forecast for this year


Allogene Therapeutics share price average forecast for Jul 2022 is: 10.5983 The dynamics are negative.
Allogene Therapeutics share price average forecast for Aug 2022 is: 10.7679 The dynamics are positive.
Allogene Therapeutics share price average forecast for Sep 2022 is: 10.4664 The dynamics are negative.
Allogene Therapeutics share price average forecast for Oct 2022 is: 9.41975 The dynamics are negative.
Allogene Therapeutics share price average forecast for Nov 2022 is: 8.78863 The dynamics are negative.
Allogene Therapeutics share price average forecast for Dec 2022 is: 9.26322 The dynamics are positive.


Allogene Therapeutics stock Forecast for 2023

Month Rate Forecast MIN Rate MAX Rate Volati-
lity, %
Jan 9.14 8.81 9.87 10.66 %
Feb 9.15 8.90 9.71 8.39 %
Mar 9.13 8.86 9.54 7.09 %
Apr 8.25 8.08 8.89 9.09 %
May 8.39 8.07 8.78 8.12 %
Jun 8.20 8.00 8.42 5.06 %
Jul 7.94 7.33 8.45 13.25 %
Aug 8.04 7.78 8.22 5.38 %
Sep 7.95 7.56 8.13 7.04 %
Oct 7.73 7.39 8.20 9.81 %
Nov 8.41 8.10 9.09 10.83 %
Dec 8.74 8.47 9.33 9.18 %

Allogene Therapeutics stock Forecast for 2024

Month Rate Forecast MIN Rate MAX Rate Volati-
lity, %
Jan 9.23 8.55 9.55 10.53 %
Feb 8.44 8.18 9.05 9.69 %
Mar 8.36 7.86 8.67 9.35 %
Apr 8.00 7.52 8.51 11.65 %
May 7.86 7.43 8.10 8.24 %
Jun 7.66 7.13 7.86 9.36 %
Jul 8.04 7.60 8.60 11.59 %
Aug 8.61 7.93 8.92 11.10 %
Sep 9.42 8.79 10.09 12.89 %
Oct 8.96 8.29 9.57 13.39 %
Nov 8.12 7.61 8.45 9.90 %
Dec 8.04 7.68 8.64 11.16 %



Allogene Therapeutics stock Forecast for 2025

Month Rate Forecast MIN Rate MAX Rate Volati-
lity, %
Jan 7.87 7.49 8.19 8.56 %
Feb 7.55 7.16 7.73 7.42 %
Mar 7.65 7.14 7.85 8.97 %
Apr 7.34 7.12 7.64 6.73 %
May 7.75 7.18 8.14 11.80 %
Jun 8.18 7.97 8.47 5.80 %
Jul 8.10 7.46 8.29 10.06 %
Aug 8.88 8.42 9.54 11.73 %
Sep 8.64 8.33 8.97 7.13 %
Oct 8.14 7.62 8.74 12.77 %
Nov 8.28 7.93 8.91 10.97 %
Dec 8.47 8.06 9.03 10.69 %

Allogene Therapeutics stock Forecast for 2026

Month Rate Forecast MIN Rate MAX Rate Volati-
lity, %
Jan 8.53 8.20 8.90 7.95 %
Feb 8.62 8.31 9.18 9.40 %
Mar 8.80 8.44 9.46 10.87 %
Apr 9.64 9.36 10.21 8.31 %
May 9.28 9.00 10.02 10.19 %
Jun 10.01 9.74 10.33 5.72 %
Jul 9.90 9.40 10.61 11.38 %
Aug 9.96 9.76 10.50 7.11 %
Sep 10.40 10.17 11.01 7.65 %
Oct 9.75 9.38 9.97 5.87 %
Nov 9.53 8.88 9.73 8.72 %
Dec 9.03 8.57 9.27 7.59 %

Allogene Therapeutics overview

Allogene Therapeutics Address

210 EAST GRAND AVENUE, SOUTH SAN FRANCISCO, CA, US

Market Capitalization

1 573 856 000 $

EBITDA

-134 911 008

PE Ratio

None

PEG Ratio

None

Dividend Per Share

0

Dividend Yield

0

EPS

-2.2

Quarterly Earnings Growth YOY

0

Quarterly Revenue Growth YOY

-0.998

Trailing PE

-

Forward PE

-

EV To Revenue

4884.98

EV To EBITDA

-

52 Week High

27.86

52 Week Low

6.43

50 Day Moving Average

8.36

200 Day Moving Average

13.7

Shares Outstanding

143600000

Shares Float

Shares Short Prior Month

Short Ratio

Percent Insiders

Percent Institutions



Other Healthcare sector assets

Name Symbol Last Close Price Change
Abbott Laboratories
ABT 109.45 (24.06.2022) 3.05 %
AbbVie Inc.
ABBV 152.34 (24.06.2022) 1.93 %
Aeterna Zentaris Inc.
AEZS 0.1887 (24.06.2022) -1.67 %
Allakos Inc.
ALLK 3.43 (24.06.2022) -1.72 %
Allogene Therapeutics, Inc.
ALLO 12.19 (23.06.2022) 1.92 %
Amgen Inc.
AMGN 245.37 (24.06.2022) 0.94 %
Aphria Inc.
APHA 15.38 (07.05.2021) 0.00 %
Atara Biotherapeutics, Inc.
ATRA 7.31 (24.06.2022) -0.54 %
Aurora Cannabis Inc.
ACB 1.53 (24.06.2022) 7.75 %
Becton Dickinson and Company
BDX 250.92 (24.06.2022) 3.46 %
Biogen Inc.
BIIB 211.93 (24.06.2022) 0.26 %
Biohaven Pharmaceutical Holding Company Ltd.
BHVN 143.79 (24.06.2022) -0.28 %
BioNTech SE
BNTX 134.04 (24.06.2022) 1.32 %
bluebird bio, Inc.
BLUE 4.4 (24.06.2022) 2.80 %
Boston Scientific Corp.
BSX 38.02 (24.06.2022) 2.92 %
Bristol-Myers Squibb Company
BMY 78.96 (24.06.2022) 1.63 %
Canopy Growth Corp.
CGC 3.77 (24.06.2022) 4.72 %
Castle Biosciences, Inc.
CSTL 23.83 (24.06.2022) 7.78 %
CLOVER HEALTH INVESTMENTS, CORP
CLOV 3.16 (07.01.2022) -5.67 %
Eli Lilly and Company
LLY 242.27 (04.02.2022) 0.00 %
Emergent BioSolutions Inc.
EBS 32.76 (24.06.2022) 1.30 %
Exelixis, Inc.
EXEL 18.56 (17.06.2022) 5.63 %
G1 Therapeutics, Inc.
GTHX 5.54 (24.06.2022) 4.53 %
Gilead Sciences, Inc.
GILD 63.08 (24.06.2022) 0.80 %
GlaxoSmithKline plc
GSK 43.69 (24.06.2022) 2.20 %
GoodRx Holdings, Inc.
GDRX 6.96 (24.06.2022) 3.73 %
GW Pharmaceuticals plc.
GWPH 218.96 (05.05.2021) 0.00 %
Incyte Corp.
INCY 78.19 (24.06.2022) 4.56 %
Inovio Pharmaceuticals, Inc.
INO 1.94 (24.06.2022) -3.48 %
Johnson & Johnson
JNJ 182.29 (24.06.2022) 1.46 %
Medtronic plc.
MDT 90.22 (24.06.2022) 1.75 %
Merck & Co., Inc.
MRK 93.13 (24.06.2022) 1.23 %
Moderna, Inc.
MRNA 144.27 (24.06.2022) 0.71 %
Novartis AG
NVS 84.83 (24.06.2022) 3.63 %
Novavax, Inc.
NVAX 51.67 (24.06.2022) -0.27 %
ObsEva SA
OBSV 1.89 (24.06.2022) -0.53 %
OrganiGram Holdings Inc.
OGI 1.06 (24.06.2022) 7.52 %
Pfizer Inc.
PFE 51.59 (24.06.2022) 2.99 %
Regeneron Pharmaceuticals, Inc.
REGN 612.49 (24.06.2022) 0.84 %
Sanofi
SNY 53.42 (24.06.2022) 5.95 %
Schrodinger, Inc.
SDGR 30.41 (24.06.2022) 3.26 %
Senseonics Holdings, Inc.
SENS 1.01 (24.06.2022) -1.94 %
Sorrento Therapeutics, Inc.
SRNE 2.07 (24.06.2022) -9.21 %
Stryker Corp.
SYK 204.43 (24.06.2022) 2.18 %
Sundial Growers Inc.
SNDL 0.39 (24.06.2022) 5.41 %
Teva Pharmaceutical Industries Lim. (TEVA)
TEVA 7.74 (24.06.2022) 0.91 %
Thermo Fisher Scientific Inc.
TMO 544.81 (24.06.2022) 0.78 %
Tilray, Inc.
TLRY 3.61 (24.06.2022) 0.84 %
UnitedHealth Group, Inc.
UNH 495.64 (24.06.2022) -0.83 %
Veeva Systems Inc.
VEEV 207.04 (24.06.2022) 3.56 %
Zomedica Corp.
ZOM 0.2535 (24.06.2022) 5.23 %
Zynerba Pharmaceuticals, Inc.
ZYNE 1.25 (24.06.2022) 4.17 %


Denial of responsibility:

The portal leoprophet.com is not responsible for the loss of your money as a result of your use of the information contained on the site, including data, quotes, charts and forecasts. Operations in the stock, foreign exchange and commodity markets involve a high level of risk, and you are solely responsible for your operations. Only speculate with money that you can afford to lose. All prices and forecasts for stocks, indices, futures are indicative and should not be trade dependent. The portal is not responsible for any losses that you may incur as a result of using this data.